In turn, Rajendiran et al. indicated miR-940 as a potential prostate cancer biomarker (Rajendiran et al. 2021), while Ma et al. showed its protective effect in the early stage of breast cancer, which results from targeting, inter alia, TNF-α signaling (Ma et al. 2021). This evidence concerns the gene TNF and Familial prostate cancer.